Echo Therapeutics has reported positive results from a clinical study of its Symphony tCGM system, designed to provide real-time blood glucose data continuously and cost-effectively. Designed as a non-invasive, wireless, transdermal ...
Tags: Echo Therapeutics, clinical study, Symphony tCGM system, CG-EGA
Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application (ANDA) for Pioglitazone tablets USP, 15mg, 30mg and 45mg. Previously, FDA has also approved the company's ANDA for Pioglitazone Hydrochloride and ...
Sanofi India will commercially launch the first Indian-manufactured re-usable insulin pen, AllStar, in India, in October 2012. Developed especially for patients in emerging markets, AllStar is meant for insulinized patients using Sanofi's ...
Tags: Insulin Pen, emerging markets, Sanofi's insulin portfolio
Boehringer Ingelheim and Eli Lilly and Company have received European Commission marketing authorization for Jentadueto (linagliptin/metformin hydrochloride) tablets. Jentadueto is a new, single-tablet treatment option, taken twice daily, ...
Tags: marketing authorization, Jentadueto tablets, glycemic control